46591f4ee7282027fc9c8a38a4e1b681.jpg

Revenues Up 70% in FY2016 for ExOne, Net Losses Reduced Significantly 3D Printing Processes

by Business

Industrial binder jetting 3D printer manufacturer ExOne closed FY 2016 last December 31st with gross profit and gross margin for significantly improved compared to the prior year. Sales for the year totaled $14.2 million, up significantly from last year’s $8.3 million. FY 2016 was driven by higher volume, especially large, indirect machine sales, and improved efficiencies. As previously noted, 2015 included costs associated with the Company’s expanded global facilities integration as well as its European ERP system implementation.

ad3418b026f6c3a5dbf4028ee509d6dd.jpg

Stratasys FY2016 losses reduced significantly, slow business improvement AM Industry

by Business

Stratasys, the current 3D printing industry market leader in terms of global sales, reported revenues $672.5 million in Stratasys FY2016 results compared to $696.0 million for fiscal 2015. This relatively contained decrement came with a huge reduction in GAAP net losses: $77.2 million, or ($1.48) per diluted share, compared to $1.4 billion, or ($26.64) per diluted share, for fiscal 2015.

a9bd79ef9a69352aa7c54735e1afe2af.jpg

Stratasys Opens Enrollment for 3DHEART Clinical Study on Effects of 3D Printed Heart Models in Surgery Medical

by Business

Stratasys, the 3D printing and additive manufacturing solutions market leader, today announced enrollment is now open for 3DHEART, an investigator initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3D printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.